Cargando…
Performance of a targeted cell‐free DNA prenatal test for 22q11.2 deletion in a large clinical cohort
OBJECTIVE: 22q11.2 deletion is more common than trisomies 18 and 13 combined, yet no routine approach to prenatal screening for this microdeletion has been established. This study evaluated the clinical sensitivity and specificity of a targeted cell‐free DNA (cfDNA) test to screen for fetal 22q11.2...
Autores principales: | Bevilacqua, E., Jani, J. C., Chaoui, R., Suk, E.‐K. A., Palma‐Dias, R., Ko, T.‐M., Warsof, S., Stokowski, R., Jones, K. J., Grati, F. R., Schmid, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518527/ https://www.ncbi.nlm.nih.gov/pubmed/34090308 http://dx.doi.org/10.1002/uog.23699 |
Ejemplares similares
-
Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions
por: Blagowidow, Natalie, et al.
Publicado: (2023) -
Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022) -
Variety of prenatally diagnosed congenital heart disease in 22q11.2 deletion syndrome
por: Lee, Mi-Young, et al.
Publicado: (2014) -
Obesity in adults with 22q11.2 deletion syndrome
por: Voll, S, et al.
Publicado: (2016) -
Disrupted anatomic networks in the 22q11.2 deletion syndrome
por: Schmitt, J. Eric, et al.
Publicado: (2016)